CardioDx Announces Positive Results From Clinical Utility Study Evaluating the Corus(R) CAD Blood Test's Influence on Clinical Decision-Making in the Assessment of Obstructive Coronary Artery Disease in Women
April 01, 2015 08:00 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Apr 1, 2015) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the publication of a new study examining the...
Insulet Announces Appointment of Michael Levitz as Chief Financial Officer
March 30, 2015 16:01 ET
|
Insulet Corporation
BILLERICA, MA--(Marketwired - Mar 30, 2015) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced...
National Panel of Multidisciplinary Experts Addresses the Unmet Needs in Assessing Coronary Artery Disease in Women
March 11, 2015 08:00 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Mar 11, 2015) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the publication of "The Diagnosis of CAD in...
Insulet Corporation to Present at Upcoming Investor Conferences
February 28, 2015 12:00 ET
|
Insulet Corporation
BILLERICA, MA--(Marketwired - Feb 28, 2015) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced...
Insulet Reports Fourth Quarter and Full Year 2014 Financial Results
February 26, 2015 16:01 ET
|
Insulet Corporation
BILLERICA, MA--(Marketwired - Feb 26, 2015) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced...
Insulet Corporation to Assume Distribution Rights for OmniPod(R) System in Canada
February 26, 2015 08:00 ET
|
Insulet Corporation
BILLERICA, MA--(Marketwired - Feb 26, 2015) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced...
Ornim Medical Announces Groundbreaking Results Validating Benefit of Real-Time Noninvasive Monitoring With c-FLOW(TM) in Restoring Brain Blood Flow in Acute Stroke Patients
February 17, 2015 06:00 ET
|
Ornim Medical
KFAR SABA, ISRAEL--(Marketwired - Feb 17, 2015) - Ornim Medical, Inc., a biomedical technology company pioneering noninvasive patient monitoring solutions for cerebral and tissue blood flow,...
Insulet Appoints John Fallon, M.D. as New Lead Director
February 10, 2015 17:00 ET
|
Insulet Corporation
BILLERICA, MA--(Marketwired - Feb 10, 2015) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today...
Insulet Further Enhances Executive Leadership Team to Drive Improved Commercial and Operational Performance
February 10, 2015 17:00 ET
|
Insulet Corporation
BILLERICA, MA--(Marketwired - Feb 10, 2015) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today...
Insulet Corporation to Report Fourth Quarter and Full Year 2014 Financial Results on February 26, 2015
February 05, 2015 17:20 ET
|
Insulet Corporation
BILLERICA, MA--(Marketwired - Feb 5, 2015) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced...